T cell immune regulator 1, ATPase H+ transporting V0 subunit a3
آخر تحديث 18 Aug 2020
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
ال TCIRG1 gene provides instructions for making one part, the a3 subunit, of a large protein complex known as a vacuolar H+-ATPase (V-ATPase). V-ATPases are a group of similar complexes that act as pumps to move positively charged hydrogen atoms (protons) across membranes. This movement of protons helps regulate the relative acidity (pH) of cells and their surrounding environment. Tight control of pH is necessary for most biological reactions to proceed properly.
Normal function
ال TCIRG1 gene provides instructions for making one part, the a3 subunit, of a large protein complex known as a vacuolar H+-ATPase (V-ATPase). V-ATPases are a group of similar complexes that act as pumps to move positively charged hydrogen atoms (protons) across membranes. This movement of protons helps regulate the relative acidity (pH) of cells and their surrounding environment. Tight control of pH is necessary for most biological reactions to proceed properly.
The V-ATPases containing the a3 subunit play an essential role in specialized cells called osteoclasts. These cells break down bone tissue as part of the normal process of bone remodeling, in which old bone is removed and new bone is created to replace it. Bones are constantly being remodeled, and the process is carefully controlled to ensure that bones stay strong and healthy.
On the surface of osteoclasts, V-ATPases are embedded in a specialized, highly folded membrane called the ruffled border. The ruffled border faces the surface of bone, where it helps form a tightly sealed compartment between the osteoclast and the bone surface. V-ATPases pump protons into the compartment, making it very acidic. This acidic environment is necessary to break down bone.
Conditions referring to this gene or chromosome
Other names
Atp6i
ATP6N1C
ATP6V0A3
ATPase, H+ transporting, 116kD
OC-116
OC-116 kDa
OC-116kDa
OC116
OPTB1
osteoclastic proton pump 116 kDa subunit
specific 116-kDa vacuolar proton pump subunit
Stv1
T cell immune response cDNA7 protein
T-cell immune regulator 1
T-cell immune regulator 1, ATPase H+ transporting V0 subunit a3
T-cell immune response cDNA 7
T-cell immune response cDNA7 protein
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein a
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3
T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3
TIRC7
V-ATPase 116 kDa
V-ATPase 116-kDa
V-type proton ATPase 116 kDa subunit a
V-type proton ATPase 116 kDa subunit a isoform 3
vacuolar proton translocating ATPase 116 kDa subunit A
Vph1
VPP3_HUMAN
Related patient information and medicines
Patient information leaflet
اضطرابات الغدة النخامية
This leaflet gives a brief overview of the pituitary gland و ال الهرمونات it makes. The pituitary gland is found at the base of the brain and is 'pea-sized'. The pituitary gland is an overall controller of a number of other glands in the body, overseeing the function of these organs through hormones. Some of the pituitary gland disorders.
%20and%20Matcha%20together%3F/og.png)
Patient information leaflet
هل يمكنني تناول سيرتيكان (إيفيروليموس) والماشا معًا؟
Drinking matcha tea while taking Certican (everolimus) may increase the levels of the medication in your bloodstream. This could lead to an increased risk of side effects, such as mouth ulcers, infections, or kidney problems. Why this happens Certican is broken down in the body by a specific enzyme (CYP3A4) and a transport protein.
Patient information leaflet
متلازمة تيرنر
Turner syndrome is a genetic condition that only affects girls. The most characteristic features of the syndrome are being short, having certain physical features (detailed below), and ovaries that do not work properly. Although there is no cure, there are treatments that can help most girls with Turner syndrome lead relatively normal lives. It.
Patient information leaflet
Medical cannabis in palliative care
Medical cannabis refers to medicines derived from the cannabis plant. In the UK, cannabis based medicinal products (CBMPs) can be prescribed by specialist doctors to help manage symptoms associated with certain medical conditions. They contain substances called cannabinoids. The two cannabinoids most used in medical treatments are: Cannabidiol.
Patient information leaflet
داء ترسب الأصبغة الدموية
The main treatment is the regular removal of blood which helps to remove the excess iron from the body. If treatment is started early, before complications occur, then the outlook for people with haemochromatosis is very good. What is haemochromatosis. People with haemochromatosis have inherited a faulty gene, which directs the body to absorb too.
%20vaccination/og.png)
Patient information leaflet
التطعيم ضد فيروس الجهاز التنفسي المخلوي (RSV)
The RSV vaccine helps protect babies and older people from the common infectious disease of the airways and lungs. Here we have information about the respiratory syncytial virus (RSV) vaccine and who should get it. What is the RSV vaccine. RSV is a common virus which causes lung infections (respiratory tract disease). An RSV infection can happen.
قراءة إضافية ومراجع
- T cell immune regulator 1, ATPase H+ transporting V0 subunit a3; MedlinePlus, National Library of Medicine.
- Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK, Wallbrandt P, Zecca L, Notarangelo LD, Vezzoni P, Villa A. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet. 2000 Jul;25(3):343-6. doi: 10.1038/77131.
- Kornak U, Schulz A, Friedrich W, Uhlhaas S, Kremens B, Voit T, Hasan C, Bode U, Jentsch TJ, Kubisch C. Mutations in the a3 subunit of the vacuolar H(+)-ATPase cause infantile malignant osteopetrosis. Hum Mol Genet. 2000 Aug 12;9(13):2059-63. doi: 10.1093/hmg/9.13.2059.
- Nishi T, Forgac M. The vacuolar (H+)-ATPases--nature's most versatile proton pumps. Nat Rev Mol Cell Biol. 2002 Feb;3(2):94-103. doi: 10.1038/nrm729.
- Scimeca JC, Quincey D, Parrinello H, Romatet D, Grosgeorge J, Gaudray P, Philip N, Fischer A, Carle GF. Novel mutations in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile malignant osteopetrosis. Hum Mutat. 2003 Feb;21(2):151-7. doi: 10.1002/humu.10165.
- Sobacchi C, Frattini A, Orchard P, Porras O, Tezcan I, Andolina M, Babul-Hirji R, Baric I, Canham N, Chitayat D, Dupuis-Girod S, Ellis I, Etzioni A, Fasth A, Fisher A, Gerritsen B, Gulino V, Horwitz E, Klamroth V, Lanino E, Mirolo M, Musio A, Matthijs G, Nonomaya S, Notarangelo LD, Ochs HD, Superti Furga A, Valiaho J, van Hove JL, Vihinen M, Vujic D, Vezzoni P, Villa A. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum Mol Genet. 2001 Aug 15;10(17):1767-73. doi: 10.1093/hmg/10.17.1767.
- Susani L, Pangrazio A, Sobacchi C, Taranta A, Mortier G, Savarirayan R, Villa A, Orchard P, Vezzoni P, Albertini A, Frattini A, Pagani F. TCIRG1-dependent recessive osteopetrosis: mutation analysis, functional identification of the splicing defects, and in vitro rescue by U1 snRNA. Hum Mutat. 2004 Sep;24(3):225-35. doi: 10.1002/humu.20076.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
18 Aug 2020 | أحدث إصدار
1 Sept 2010 | نُشر في الأصل
انضم إلى المحادثة
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اسأل، شارك، تواصل.
تصفح المناقشات، اطرح الأسئلة، وشارك التجارب عبر مئات المواضيع الصحية.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.